Conference Coverage

Environmental and Behavioral Interventions May Alleviate Nonmotor Symptoms of Parkinson’s Disease


 

References

Some studies show emotion recognition deficits in people with Parksinon’s disease. Buxton et al found that people with Parkinson’s disease were significantly different in their ability to detect subtle expressions of facial emotion and emotions conveyed by voices, compared with control participants. As an intervention, caregivers might try amplifying their expressions to help patients pick up emotional cues, said Dr. Cronin-Golomb.

Interventions for Sleep
Exercise interventions may improve sleep, although few studies of exercise interventions use sleep as an outcome measure. Nascimento et al showed a trend for improved sleep among patients who completed aerobic and conditioning exercise. Patients also had improved subjective quality of life.

CBT for insomnia is an effective treatment for primary insomnia and for insomnia related to many other conditions, but it probably is not an appropriate intervention for people with Parkinson’s disease because of its sleep restriction component. “For somebody at risk for falls, this is probably not something you want to be doing,” said Dr. Cronin-Golomb. Some evidence suggests that bright-light therapy might improve sleep, mood, and motor function, and that melatonin may improve subjective sleep quality, Dr. Cronin-Golomb said.

Jake Remaly

Pages

Recommended Reading

Patients’ Motor Subtypes of Parkinson’s Disease May Change Over Time
MDedge Neurology
Exercise May Improve White Matter Integrity in Patients With Parkinson’s Disease
MDedge Neurology
Oral device reduced obstructive sleep apnea, not sleepiness
MDedge Neurology
Does Dopamine Transporter Deficit Identify Prodromal Parkinson’s Disease in Patients With REM Sleep Behavior Disorder?
MDedge Neurology
Inhaled Levodopa Rapidly Improves Off States in Patients With Parkinson’s Disease
MDedge Neurology
Initiating Regular Exercise Is Associated With Slower Decline in Quality of Life in Parkinson’s Disease
MDedge Neurology
Novel Treatment for Rett Syndrome Shows Efficacy in Phase II Studies
MDedge Neurology
Alpha-Synuclein Is a Target of New Therapeutic Strategies for Parkinson’s Disease
MDedge Neurology
Earlier Treatment With Rotigotine May Have Long-Term Benefit for Patients With Parkinson’s Disease
MDedge Neurology
Does Low Muscle Strength Predict Parkinson’s Disease?
MDedge Neurology

Related Articles